NCT02554773: An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 34 taking part
- Started
- 18 Sep 2015
- Primary completion
- 21 Mar 2023
- Arms
- Fitusiran
- Results
- Posted on the registry
- 18 Sep 2015: Trial registered
- 18 Sep 2015: Trial started
- 21 Mar 2023: Trial completed
- 5 Jun 2024: Trial results posted